![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1705666
¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀå : Á¦Ç° À¯Çüº°, ¸ð´ÏÅ͸µ ±â±â, µ¿¹° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº°Pet Health Screening Market, By Product Type, Monitoring Devices, By Animal Type, By End User, By Application, By Geography |
¼¼°è ¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀåÀº 2025³â 26¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 41¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.3%ÀÇ CAGR(¿¬Æò±Õ ¼ºÀå·ü)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§ | º¸°í¼ »ó¼¼ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2024³â | 2025³â ½ÃÀå ±Ô¸ð | 26¾ï 8,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£ : 2025-2032³â CAGR | 6.30 | 2032³â °¡Ä¡ ¿¹Ãø | 41¾ï 1,000¸¸ ´Þ·¯ |
¹Ý·Áµ¿¹° °Ç°°ËÁø ¼¼°è ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ°·üÀÇ Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ç¾ú½À´Ï´Ù. ´Ù¾çÇÑ ¹Ý·Áµ¿¹° °Ç°°ËÁø °Ë»ç´Â Áúº´ÀÇ Á¶±â ¹ß°ß°ú Àû½Ã Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ¹Ý·Áµ¿¹°ÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÏ°í ¹Ý·Áµ¿¹°ÀÇ Àΰ£È°¡ ÁøÇàµÊ¿¡ µû¶ó ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀº ¹Ý·Áµ¿¹°ÀÇ ¿¹¹æÀû °Ç°°ü¸®¿¡ ´õ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¹ßÀüÀ¸·Î ÇÑ ¹øÀÇ °Ë»ç·Î ¿©·¯ Áúº´À» °Ë»çÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Áø´Ü µµ±¸°¡ °³¹ßµÇ¾î ¹Ý·Áµ¿¹° º¸È£ÀÚ¿¡°Ô º¸´Ù Æí¸®ÇÑ °Ë»ç°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ¹Ý·Áµ¿¹° °Ç° ÁöÃâ Áõ°¡¿Í ÷´Ü Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼±Áø±¹ÀÇ ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡, ¹Ý·Áµ¿¹° °Ç°°ü¸®¿¡ ´ëÇÑ ÁöÃâ Áõ°¡, ¼öÀÇÇÐ Áø´ÜÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. 2025³â 10¿ù ¹Ì±¹ ¼öÀÇ»çÇùȸ¿¡ µû¸£¸é, ¹Ì±¹ ³» ¾à 8,500¸¸ °¡±¸°¡ ¹Ý·Áµ¿¹°À» Ű¿ì°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Ý·Áµ¿¹° Àα¸ÀÇ Áõ°¡´Â ´Ù¾çÇÑ ¼±º°°Ë»ç ¹× Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¾ÈÁ¤ÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¼ºÀå ¿äÀÎÀº Áúº´ Á¶±â ¹ß°ßÀÇ ÀÌÁ¡¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÔ´Ï´Ù. Çõ½ÅÀûÀÎ ¿©·¯ Áúº´¿¡ ´ëÇÑ ¼±º° °Ë»ç°¡ °¡´ÉÇØÁö¸é¼ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÁ¤ °í±Þ Áø´Ü ÀýÂ÷¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå È®´ë¸¦ ¾î´À Á¤µµ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, º¸´Ù Àú·ÅÇÑ ¹Ý·Áµ¿¹° °ËÁø ¼Ö·ç¼ÇÀÇ ¿¬±¸ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ¾î ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ÁøÀÔ ±â¾÷µé¿¡°Ô Å« ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
º» Á¶»ç ´ë»óÀÇ ÁÖ¿ä ±â¾÷Àº Zoetis Inc., IDEXX Laboratories Inc., Mars Petcare, Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, Ceva Sante Animale, Virbac, Neogen Corporation, PetIQ, Vetoquinol S.A., Heska Corporation, Abaxis, Inc., Antech Diagnostics, Trupanion, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹Ý·Áµ¿¹° °Ç°°ËÁø ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Global Pet Health Screening Market is estimated to be valued at USD 2.68 Bn in 2025 and is expected to reach USD 4.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 2.68 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.30% | 2032 Value Projection: | USD 4.11 Bn |
The global pet health screening market has been witnessing significant growth in the recent past owing to rising pet adoption and increasing awareness about pet wellness among pet owners. Various pet health screening tests help detect diseases at an early stage and enable timely treatment, thereby improving the quality of life for pets. Rising disposable incomes and growing humanization of pets have prompted owners to invest more in preventive healthcare for their pets. Furthermore, technological advancements have enabled the development of innovative diagnostic tools that can screen for multiple diseases with just one test, making screening more convenient for pet owners. The market is expected to continue growing at a steady pace over the forecast period driven by increasing pet health expenditure and growing demand for advanced diagnostic solutions.
The key drivers propelling the global pet health screening market include rising pet adoption in developed nations, growing expenditure on pet healthcare, and advancements in veterinary diagnostics. In October 2025, according to American Veterinary Medical Association, around 85 million American households own a pet. This growing pet population base is creating steady demand for various screening and diagnostic tests. Another important growth driver is the increasing awareness among owners regarding early disease detection benefits. Availability of innovative multi-disease screening tests is also spurring market growth. However, high costs associated with certain advanced diagnostic procedures could hamper market expansion to some extent. On the upside, ongoing research & development towards more affordable pet screening solutions is expected to present significant opportunities for market participants over the coming years.
This report provides in-depth analysis of the global pet health screening market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pet health screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Zoetis Inc., IDEXX Laboratories Inc., Mars Petcare, Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, Ceva Sante Animale, Virbac, Neogen Corporation, PetIQ, Vetoquinol S.A., Heska Corporation, Abaxis, Inc., Antech Diagnostics, and Trupanion, Inc.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet health screening market